Welcome to Tivic Health Systems' Third Quarter 2024 Financial Results and Operational Update Conference Call. This call has been pre-recorded and questions you have submitted in advance will be answered following the prepared remarks. This call is being webcast and the replay will be available on the IR section of the company's website for three months. Before we begin, let me remind you that during today's call, management will be making various forward-looking statements. Investors are cautioned that these forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated by our forward-looking statements. Please read the Safe Harbor Statement contained in the press release we issued earlier today, as well as those contained in Tivic Health's filings with the SEC, including its annual report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, under the heading Risk Factors, as well as the company's subsequent filings with the SEC. Now, let me turn the call over to Jennifer Ernst, to Tivic Health's Chief Executive Officer.

Thank you to our operator, and of course, thank you to everyone who is listening today on this call and also those of you that are listening in playback. So, as we begin this report on Q3, I'll highlight that I've talked quite a bit about our vagus nerve stimulation program in the recent calls. Today I'd like to touch a little more broadly on all three legs of our strategy to build shareholder value and to create a growth business. Now, that starts first with turning our ClearUP product line into a profitable business line. Second, we're looking at leveraging our expertise in bioelectronic medicine to generate new business opportunities. And that is specifically advancing a novel approach to non-invasive vagus nerve stimulation, that we have been making significant progress in the last few quarters; and finally, streamlining our corporate operations to manage overhead costs in the public company. We've made significant progress on all three, and the numbers that I'm reporting this quarter will only tell part of the story, but they're absolutely the place to start. I'd also like to highlight, as we're talking about our numbers, that Lisa Wolf joined us this quarter as our Interim CFO. She's taking over the reins from Kimberly Bambach, who continues with us on a consulting basis. Lisa has been part of the Tivic team now for about two years, been part of the team that streamlined our public operating costs, and has been working side by side with Kim. So, I'm very excited to welcome her to this new role, particularly with more than 30 years of financial leadership experience that encompasses both public and private finance and accounting. The two years she spent with the Tivic team prior to this role, she's bringing to the table both a…